NIH NHLBI Funding: Eligibility, Application Process, and Fit Checklist

Eligibility, typical funding (R01: $250K–$450K direct/year · SBIR Phase II: ~$2M), how to apply, review criteria, and open status for NIH NHLBI funding. Last reviewed 2026-07-09.

Agency: NIH — National Heart, Lung, and Blood Institute. Mechanism: Grants, cooperative agreements, and contracts.

Status: Active — ongoing NHLBI mechanisms

Typical funding: R01: $250K–$450K direct/year · SBIR Phase II: ~$2M

What is NIH NHLBI funding?

NHLBI supports research on cardiovascular, pulmonary, and blood diseases—including devices, therapeutics, and population science. Funding spans basic discovery through clinical and implementation research.

NHLBI (National Heart, Lung, and Blood Institute) is administered by NIH — National Heart, Lung, and Blood Institute. The funding mechanism is Grants, cooperative agreements, and contracts. This guide covers eligibility, funding size, how to apply, reviewer expectations, and whether the pathway is open.

Program goals

  • Improve prevention and treatment of heart, lung, and blood diseases
  • Advance translational research for cardiometabolic and pulmonary conditions
  • Support health equity in cardiovascular and lung health

Recent program activity

NHLBI publishes FOAs in cardiovascular genomics, heart failure, COPD, and blood disorders.

Who NIH NHLBI funding is for

Standard NIH applicant entities with science aligned to NHLBI mission may compete on relevant FOAs or investigator-initiated applications.

Cardiovascular, pulmonary, and hematology innovation teams pursuing NIH NHLBI programs.

If your technology does not map to NIH NHLBI mission priorities, stop here and compare related pathways before drafting.

Strong-fit applicant profiles

  • Academic medical centers and research universities
  • Medtech and biotech companies via appropriate mechanisms
  • Consortiums for clinical and implementation studies

Usually not a fit

Research without cardiovascular, pulmonary, or hematologic relevance

NIH NHLBI eligibility requirements

Before you write, confirm you meet the published NIH NHLBI eligibility rules for the active solicitation. NHLBI (National Heart, Lung, and Blood Institute) reviewers and contracting officers screen for mechanism fit early—wrong entity type or missing registrations waste months.

Eligibility is notice-specific. Treat the checklist below as the baseline, then verify against the live FOA, BAA, or NOFO.

Key eligibility requirements

  • NHLBI mission alignment
  • NIH registration and compliance
  • Study design appropriate to disease area

NIH NHLBI funding amounts and award terms

Device and translational programs may include staged funding with companion FOAs.

Typical award range for NIH NHLBI: R01: $250K–$450K direct/year · SBIR Phase II: ~$2M.

Award duration: 1–5 years.

Cost share: None for most grants.

Ranges change by solicitation. Always confirm ceilings, option years, and cost-share on the active notice.

Is NIH NHLBI open right now?

Active — ongoing NHLBI mechanisms

NHLBI opportunities remain active via NIH standard dates and institute FOAs.

Sunset / authorization note: No fixed sunset.

How often opportunities open: NIH standard receipt dates + NHLBI FOAs.

Status changes with appropriations, FOA amendments, and BAA closings. Use the official links in this guide before committing proposal spend.

Status last verified by Velawolf

2026-07-09

How to apply for NIH NHLBI

Competitive NIH NHLBI packages usually fail on process, not ideas. Sequence: confirm eligibility → lock topic/office fit → build compliance matrix → draft technical and management volumes → QA → submit.

Application process steps

  • FOA targeting and team assembly
  • NIH application development
  • Review and council recommendation
  • Award negotiation

NIH NHLBI proposal / package requirements

Disease-area significance Methodological rigor and sample size logic Translation plan for device/therapeutic work

What NIH NHLBI reviewers evaluate

Evaluator expectations for NHLBI (National Heart, Lung, and Blood Institute) are mechanism-specific. Align technical claims, transition logic, and compliance evidence to how this program scores proposals—not to a generic grant template.

Review criteria

  • Significance to NHLBI priorities
  • Innovation and approach
  • Investigator and environment strength

Common NIH NHLBI application mistakes

Most weak NIH NHLBI submissions share the same failure modes: wrong mechanism fit, thin evidence, and late compliance work.

Pitfalls to avoid

  • Generic device story without cardiopulmonary context
  • Underpowered clinical plans

NIH NHLBI fit checklist (before you spend)

Use this checklist before funding a full NIH NHLBI proposal effort. If several items are missing, fix readiness—or switch pathways—first.

Readiness signals

  • NHLBI relevance documented in aims
  • Mechanism matches study stage
  • Biostatistics and study design reviewed
  • Compliance calendar managed

Typical NIH NHLBI pursuit timeline

Velawolf sequences pursuits around decision gates so teams do not burn calendar on the wrong pathway.

Engagement timeline

  • Week 1: Institute and FOA fit review
  • Weeks 2–4: Narrative and budget development
  • Weeks 4–6: Scientific and compliance review
  • Submission: NIH package submission

NHLBI proposal consulting: how Velawolf helps

NHLBI opportunities require robust scientific framing and practical execution planning. Velawolf supports teams with fit diagnostics, compliant submissions, and post-award preparation.

From opportunity targeting through final submission, our NHLBI support integrates technical narrative quality with compliance and timeline control.

If you need hands-on NHLBI proposal consulting—not just this guide—start with a fit call before proposal spend.

What we deliver

  • NHLBI opportunity and institute-fit assessment
  • Application strategy and scientific narrative support
  • Compliance mapping and submission planning
  • Budget and project timeline alignment
  • Review-cycle response support
  • Post-award startup planning

Official sources

  • NHLBI grants and training: https://www.nhlbi.nih.gov/grants-and-training

NHLBI (National Heart, Lung, and Blood Institute) FAQ

  • What is NHLBI (National Heart, Lung, and Blood Institute)? NHLBI supports research on cardiovascular, pulmonary, and blood diseases—including devices, therapeutics, and population science. Funding spans basic discovery through clinical and implementation research.
  • Who is eligible for NIH NHLBI? Standard NIH applicant entities with science aligned to NHLBI mission may compete on relevant FOAs or investigator-initiated applications.
  • How much funding does NIH NHLBI provide? Award size and terms depend on the active solicitation. Key figures to verify:
  • Is NIH NHLBI currently open / accepting applications? Open status changes with new notices, amendments, and appropriations. Check the following before you commit proposal resources:
  • How do you apply for NIH NHLBI? Follow the published process for the active solicitation. In most cases, the sequence looks like this:
  • What are NIH NHLBI proposal requirements? Reviewers expect a complete package that addresses the notice instructions. Core requirements usually include:
  • What do NIH NHLBI reviewers look for? Evaluation criteria vary by solicitation, but reviewers consistently score proposals on:
  • What are common NIH NHLBI application mistakes? Weak submissions often fail for predictable reasons:
  • How long does a NIH NHLBI pursuit typically take? Timeline depends on solicitation complexity and internal readiness. A typical Velawolf-supported pursuit follows these phases:

Velawolf support

NHLBI opportunities require robust scientific framing and practical execution planning. Velawolf supports teams with fit diagnostics, compliant submissions, and post-award preparation.

  • NHLBI opportunity and institute-fit assessment
  • Application strategy and scientific narrative support
  • Compliance mapping and submission planning
  • Budget and project timeline alignment
  • Review-cycle response support
  • Post-award startup planning